Literature DB >> 11983199

Effects of diabetes mellitus and acute hypertension on plasma nitric oxide and endothelin concentrations in rats.

Pervin Vural1, Aydin Cevik, Asli Curgunlu, Mukaddes Canbaz.   

Abstract

AIM: To examine the plasma nitrate/nitrite (NOx-two end products of the nitric oxide metabolism) and endothelin (ET) concentrations, and response to acute adrenaline induced hypertension in diabetic rats.
MATERIALS AND METHODS: Four groups of 4-month-old rats were used: control rats (C, n=10) rats received adrenaline (A, 40 microg/kg i.v., n=10), rats received streptozotocin (S, 50 mg/kg i.v., n=8), and rats received STZ and adrenaline (SA, n=9). The experiments were performed 4 weeks after the STZ administration. Plasma NOx, ET, glucose, and mean arterial blood pressure (MAP) were measured.
RESULTS: Plasma ET concentrations were significantly increased in diabetic rats (S and SA) in comparison with the controls and adrenaline-only administered rats. NOx concentrations in diabetic groups (S and SA) were significantly decreased in comparison with the controls. Acute adrenaline induced hypertension in diabetes leads to a significant decrease of NOx concentrations in comparison with the controls, adrenaline-only administered and STZ-only administered rats. There was no difference between the MAP in diabetic and control rats. Adrenaline injection caused a significant increase of MAP in A and SA groups. Plasma glucose concentrations in diabetic rats (S and SA) were significantly increased in comparison with the nondiabetic groups (C and A). There was a weak but significant correlation between the NOx and ET concentrations in the controls, which probably reveal the balance between these vasoactive factors. In A, S, and SA groups, no significant correlation between the NOx/ET was found.
CONCLUSION: An impairment of the NOx and ET formation could be involved in the pathogenesis of diabetes mellitus and especially acute hypertension and diabetes. A lack of correlation between the NOx and ET probably indicated that in diabetes and acute hypertension, a primary mechanism of compensatory nitric oxide might be lost.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983199     DOI: 10.1016/s0009-8981(02)00024-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats.

Authors:  Denise M Arrick; William G Mayhan
Journal:  Microcirculation       Date:  2010-08       Impact factor: 2.628

2.  Role of aspirin activated nitric oxide synthase in controlling DOCA-salt-induced hypertension in rats through the stimulation of renal r-cortexin in kidney cortex cells.

Authors:  Uttam Kumar Maji; Tamal Kanti Ghosh; Mitali Chatterjee; Suman Bhattacharya; Sarbashri Bank; Pradipta Jana
Journal:  Int J Health Sci (Qassim)       Date:  2022 Jul-Aug

3.  L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.

Authors:  Lusliany J Rondón; M C Farges; N Davin; B Sion; A M Privat; M P Vasson; A Eschalier; C Courteix
Journal:  Eur J Nutr       Date:  2017-07-19       Impact factor: 5.614

4.  Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.

Authors:  Tarek Mk Motawi; Mohamed A Abou-Seif; Ahmed Ma Bader; Mohamed O Mahmoud
Journal:  BMC Endocr Disord       Date:  2013-08-21       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.